Focus
RSV vaccine
Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly
Research shows that, unlike tetanus and influenza vaccines, COVID-19 mRNA vaccines do not prompt the generation of durable antibody-producing cells.
|
RSV Vaccines May Increase Risk of Rare Neurological Condition
CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré syndrome in adults over 60.
|
Australia Approves First Vaccine for Infectious Respiratory Virus for Over 60s
2023 saw increases in reported cases of RSV when compared with 2022, with large numbers being seen in nearly every state.
|
White House Confirms 230,000 Additional RSV Immunization Doses for Infants Next Month
Low infant death rates from RSV and concerns about the safety of treatment have cast doubts about the immunization drive.
|
Study: Moderna’s mRNA-Based RSV Vaccine Causes High Rate of Adverse Reactions
The vaccine group suffered roughly 81 adverse events for every RSV illness the jab prevented.
|
Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
A BMJ investigation revealed Pfizer was studying preterm births as an “adverse event of special interest” in RSV trial, but didn’t inform pregnant participants.
|
‘Perfectly Reasonable to Skip’ COVID-19, Flu, RSV Fall Vaccines: Dr. McCullough
The cardiologist advised people to seek ‘early treatment’ for such infections rather than getting vaccinated.
|
Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly
Research shows that, unlike tetanus and influenza vaccines, COVID-19 mRNA vaccines do not prompt the generation of durable antibody-producing cells.
|
RSV Vaccines May Increase Risk of Rare Neurological Condition
CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré syndrome in adults over 60.
|
Australia Approves First Vaccine for Infectious Respiratory Virus for Over 60s
2023 saw increases in reported cases of RSV when compared with 2022, with large numbers being seen in nearly every state.
|
White House Confirms 230,000 Additional RSV Immunization Doses for Infants Next Month
Low infant death rates from RSV and concerns about the safety of treatment have cast doubts about the immunization drive.
|
Study: Moderna’s mRNA-Based RSV Vaccine Causes High Rate of Adverse Reactions
The vaccine group suffered roughly 81 adverse events for every RSV illness the jab prevented.
|
Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
A BMJ investigation revealed Pfizer was studying preterm births as an “adverse event of special interest” in RSV trial, but didn’t inform pregnant participants.
|
‘Perfectly Reasonable to Skip’ COVID-19, Flu, RSV Fall Vaccines: Dr. McCullough
The cardiologist advised people to seek ‘early treatment’ for such infections rather than getting vaccinated.
|